Dana Farber Cancer Institute SC-5

Boston, Massachusetts 02115

0 studies enrolling now · 2 studies all time

What they study most

Follicular Lymphoma, Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma

Studies at this site

• Study of HCD122 in Adults With Non-Hodgkin's or Hodgkin's Lymphoma Who Have Progressed After at Least Two Prior Therapies — Completed
• Study of HCD122 (Lucatumumab) and Bendamustine Combination Therapy in CD40+ Rituximab-refractory Follicular Lymphoma — Completed